News blog


  • BY: Andrew Hore |
  • POSTED: 28/04/2014 |

Infection control products supplier Tristel says that its 2013 -14 profit will be 200,000 higher than forecast.

Management says that profit will be at least 1.5m in the year to June 2014, compared with a previous forecast of 1.3m. The 2014-15 profit forecast has been raised from 1.4m to 1.8m. Cash has improved from 31.5m at the end of 2013 to more than 2.2m.

The share price rose 5p to 53.5p, which values the company at 21.4m. The shares are trading on 12 times 2013-14 earnings, falling to less than ten the following year.

Tristel says that growth is coming from the UK and overseas and across all three main product areas human healthcare, animal healthcare and contamination control. 

Download the latest AIM Journal from

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds